Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Jan 29;17(4):5193–5201. doi: 10.3892/mmr.2018.8515

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Qian et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 2. — Flow cytometry analysis of cell cycle and apoptotic rate. (A) Cell cycle analysis of the Pter, miR-19a inhibitor, Pter + miR-19a inhibitor, negative control and blank control groups. (B) Quantification of the cell cycle analysis for each treatment group. (C) Representative flow cytometry plots indicating the apoptotic rate (the early and late stage apoptosis) within Pter, miR-19a inhibitor, Pter + miR-19a inhibitor, negative control and blank control groups. (D) Quantification of the apoptotic rate for each treatment group. *P<0.05, **P<0.01 and ***P<0.001 vs. blank or negative control groups. The Pter-only treatment group was compared with the blank control group, while the miR-19a inhibitor and Pter + miR-19a inhibitor groups were compared with the negative control group. Pter, pterostilbene; miR, microRNA.